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Abstract: The main purpose of this study was to investigate the differences in glycaemic reaction in
response to various physical activities in 20 young boys (14.4 ± 1.6 years) with type 1 diabetes mellitus
(T1DM) and with either vitamin D deficiency or with suboptimal levels of vitamin D. Participants were
divided into two groups (deficiency group—DG, n = 10; suboptimal group—SG, n = 10) according to
their vitamin D levels. All patients performed aerobic and mixed (aerobic-anaerobic) physical efforts.
During the exercise, the respiratory responses and glucose levels were monitored. Biochemical blood
analyses were performed before each physical effort. The oxygen consumption was not significantly
lower in SG during both aerobic and mixed effort (4.0% and 5.6%, respectively). The glycated
haemoglobin (HbA1c) level was higher by 6.1% and the total daily dose of insulin (DDI) was higher
by 18.4% in the DG. The differences were not statistically significant. Patients with lower vitamin D
levels demonstrated an insignificantly higher glycaemic variability during days with both aerobic and
mixed exercises. An appropriate vitamin D concentration in T1DM patients’ blood may constitute
a prophylactic factor for hyperglycaemia during anaerobic training and hypoglycaemia during
aerobic training.
Keywords: type 1 diabetes; serum 25(OH)D; oxygen consumption; blood glucose; exercise intensity
1. Introduction
Type 1 diabetes mellitus (T1DM) is an autoimmune disease in which the insulin-producing
beta cells of the pancreas are destroyed by effector lymphocytes sensitized to pancreatic antigens [1].
An increasing incidence of T1DM, observed in Poland during the last 20 years, has led to the fact that
T1DM is the most common non-infectious chronic disease in the population under the age of 18 years
in Europe. The highest incidence rate is reported in developing countries of Middle-East Europe,
including Poland [2]. The data originating from different regional Polish registers, collected within
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the framework of the EURODIAB project over the last two decades, have demonstrated the dramatic
increase of T1DM rate by 300%. In the light of epidemiological data from years 1989–2004, it is
presumed that the incidence of T1DM will increase fourfold until 2025, particularly in the group of
children at the age 5–9 [1].
On the basis of current scientific knowledge and numerous publications, it is confirmed that
vitamin D plays a key role in T1DM pathogenesis. It has been proven that vitamin D deficiency
(<75 mmol/L) constitutes a risk factor for diabetes and there is evidence suggesting that vitamin D
deficiency may play a role in the development of pancreatic beta cells autoimmunity [3]. In addition,
Yuan et al. [4] have proved that higher vitamin D concentrations are related with a lower risk of type
2 diabetes development, suggesting that vitamin D plays an important role in increase of insulin
sensitivity in patients with carbohydrate metabolism disorder.
The aforementioned relation has been demonstrated by Zipitis et al. [5] in the EURODIAB study,
who have emphasized the role of vitamin D supplementation in children in reducing the risk of T1DM
development later in life. Given the currently available, however still scarce, studies it is highlighted
that the development of T1DM may be correlated with the presence of VDR (Vitamin D receptors) in
pancreatic beta cells. According to the current clinical and pre-clinical evidence, vitamin D may have a
role in T1D prevention mainly through its immunomodulatory and anti-inflammatory effects rather
than its effects on pancreatic beta-cell secretory capacity.
The vitamin D activity affects the expression of the VDR, and consequently, regulates the secretion
and the activity of insulin [6]. Furthermore, it has been revealed that calcitriol is capable to transform
proinsulin in to its active form-insulin [7]. Wimalawans et al. [8] have underlined the association
between normal range vitamin D and calcium concentrations and the prevention of insulin resistance
and T1DM. The emerging evidence shows that vitamin D, due to its role in immune system regulation
(T regulatory cells), protects pancreatic beta cells, which are still not affected by the autoimmune
process [9] therefore, it may prolong the remission period of T1DM [10]. What is more, Gabbay et al. [11],
Aliabri et al. [12] and Panjiyar et al. [10] have revealed the favorable effect of optimal vitamin D level
in patients with T1DM on metabolic control of the disease evaluated by glycated hemoglobin level
(HbA1c), C-peptide concentration, insulin sensitivity and reduction of total daily dose of insulin.
The study of Al Zubeidi et al. [13], carried out in 2016, confirmed this assumption. These researchers
showed a correlation between low serum vitamin D level and a higher incidence rate of diabetic
ketoacidosis in patients with T1DM. On the basis of their studies, Hafez et al. [14] and Panjiyar et al. [10]
recommend maintaining an optimal vitamin D level to mitigate the risk of hypoglycaemic events in this
group of patients. The goals of T1DM therapy consist not only in achieving normal glycaemic levels
and minimizing the risk of acute (i.e., hypoglycemia, diabetic ketoacidosis) and chronic complications
(i.e., nephropathy, retinopathy, neuropathy and cardiovascular disorders), but also in preserving a
normal functioning of patients in society, enabling them to lead the lifestyle approximated to that of
their peers and to realize all of the current activities, including sport practice [13].
To date, no studies exist regarding the relationship between vitamin D level in diabetic patients
and the tolerance of physical effort. Even though beneficial effects of physical effort are well known
in the healthy population, recommendations regarding physical activity in patients with T1DM are
essentially based on the results of few studies carried out in diabetic adults, frequently affected with
type 2 diabetes [15–17].
The aim of this research was to reveal the differences in glycaemic reaction in response to aerobic
and aerobic-anaerobic physical effort in young patients with T1DM diagnosed with vitamin D deficiency
or having a suboptimal vitamin D level. Before proceeding to the study, we assumed that patients with
higher vitamin D concentrations would demonstrate a better response to physical effort, measured by
the amount of absorbed oxygen. Moreover, it was hypothesised that the period of hyperglycaemia and
hypoglycaemia in this group would last shorter during the physical activity and after its completion.
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2. Materials and Methods
2.1. Characteristics of the Study Group
The study group consisted of 20 boys with T1DM diagnosed according to the criteria of ISPAD
guidelines [18], who remain under the care of the Clinic of Pediatrics, Diabetology and Endocrinology
at the University Clinical Center in Gdan´sk, Poland, a city located at latitude 54◦22′ north. The mean
age of patients was 14.4 ± 1.6 years and the mean duration of the disease was 6.7 ± 4.1 years. The body
weight in the whole study group was 59.5 ± 12.8 kg and the mean BMI was 20.2 ± 2.6 kg/m2.
The protocol of the study was explained to every participant before the enrolment in the
experiment. Patients and their parents signed the written informed consent form. Researchers obtained
the approval of the Bioethical Commission of the Medical University of Gdansk (NKBBN/397/2018).
Inclusion criteria of the research were: at least one year of T1DM duration. Patients using insulin pump
therapy integrated with continuous glucose monitoring (CGM). Medtronic sensor and insulin pumps,
Paradigm Veo and MiniMed 640G were used in the study. CGM measured real-time glycaemia and was
not blinded, therefore the researchers and the patients had continuous access to glucose concentrations.
In addition, inclusion criteria of the research were: assessment of the puberty at the stage II, IV or V
in the Tanner scale, not practicing high performance sports, lack of diabetic ketoacidosis or severe
hypoglycemia incidents during last five years and signed written consent form. The mean duration of
continuous subcutaneous insulin therapy was 6.0 ± 3.9 years (n = 20). The mean HbA1c was 7.3 ± 0.8%
(n = 20). Exclusion criteria were obesity, concomitant chronic diseases (e.g., hypothyroidism, liver,
renal disorders and coeliac disease) that may have an impact on the occurrence of hypoglycemia,
and the lack of written informed consent.
Patients did not practice any high-performance sports and their physical activity consisted of
physical education classes at school and physical recreation, approximately 2–3 times a week. The group
of 20 participants enrolled in the study was divided into two subgroups characterized by members
with vitamin D deficiency (deficiency group <50 nmol/L, n = 10,) and patients with suboptimal vitamin
D concentration (suboptimal group 50–75 nmol/L, n = 10) [19]. The participants did not receive
any vitamin D supplementation throughout the year before the study and during the study period.
The general characteristics of the study groups are presented in Table 1.
Table 1. Characteristic of the participants.
Characteristics Group DG Group SG p-Value
Age (years) 14.6 ± 1.6 14.6 ± 1.8 1.0001
Body height (cm) 170.5 ± 9.2 171.8 ± 13.3 0.8021
Body weight (kg) 59.4 ± 10.9 59.5 ± 15.0 0.9924
BMI (kg/m2) 20.4 ± 2.7 20.0 ± 2.5 0.7142
BMI percentile 51.5 ± 29.6 47.5 ± 23.6 0.7421
BMI z-score 0.20 ± 0.8 0.03 ± 0.7 0.6096
Disease duration (years) 7.4 ± 4.3 5.9 ± 4.0 0.4323
Insulin pump therapy duration (years) 6.8 ± 4.1 5.2 ± 3.7 0.3734
VO2max (ml/kg/min) 40.6 ± 5.1 39.9 ± 6.6 0.4532
VO2/AT (Watt) 27.3 ± 3.3 25.9 ± 4.2 0.7912
25(OH)D (nmol/L) 33.4 ± 10.3 64.8 ± 10.6 0.0002
Basic physical examination was performed. All children underwent physical examination,
and height and weight were taken in a standard way using Harpenden stadiometer and digital scale
(Seca, Hamburg, Germany). BMI-z score (body mass index) SDS (standard deviation score of BMI,
according to the formula: SDS-BMI = (BMI current − BMI 50 centile) / 0.5 (BMI 50 centile − BMI
3rdcentile)) was calculated with standard formulas, using the results of the OLAF study of Polish
children [20].
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2.2. Experimental Run
The experimental run consisted of three exercise tolerance tests. The objective of the first test
was to determine the physical efficiency of every participant. The second test was based on 45 min
of physical exercises, which intensity corresponded to aerobic metabolism and the third test at the
intensity of aerobic–anaerobic metabolism (combined).
All patients ate the same meal (natural yoghurt, oat flakes, banana, walnuts) two hours before
every of three exercise tolerance tests. It was composed of 60% of carbohydrates, 15% of proteins and
25% of fat. 40 g of natural yoghurt, 15 g of oat flakes, 40 g of unripe banana and 4 g of walnuts were
included in two carbohydrates units (CU). The amount of CU depended on the total daily caloric
requirement of the patient and participants received 0.7 to 0.8 units of insulin for every CU and every
fat/protein unit (FPU).
Each participant received a bolus of rapid-acting insulin analogue before the meal, which did
not affect glycaemia during the physical activity regarding the time of action of the drug. Blood
glucose concentration did not exceed 8.32 mmol/L before enrolment to the aerobic physical exercise
and 10 mmol/L before the commencement of the aerobic-anaerobic exercise. Glucose concentrations
were controlled with the use of CGM, under medical supervision during every physical tolerance effort
and one hour after its completion, and onwards up to 24 h after the training.
During the first experimental runs, all of the participants accomplished the progressive load
physical tolerance test after preliminary medical procedures. On the basis of obtained results,
researchers calculated the individual value of maximum oxygen consumption (VO2max) and anaerobic
threshold (AT) rate expressed in power units on a bicycle ergometer. These ratios were essential
to determine an individual load as a relative value of AT in subsequent physical tests. Two weeks
after, every patient completed the first experimental 45 min aerobic physical activity after preliminary
medical procedures. The load was expressed in power units (Watts) and the value was determined as
40% less than AT (Watts). After the next two weeks, patients were subjected to 30 min aerobic-anaerobic
(combined) physical activity test, which consisted of two min of AT (Watts) minus 40% and 4 min
of AT (Watts) plus 10% (Watts) alternately (5 repetitions altogether). Cardiopulmonary indices were
continuously registered during both physical tolerance tests with the use of an expiratory gas analyzer.
2.3. Physiological Analyses
VO2max was measured with the use of expiratory gas analyser Oxycon Pro (Erich JAEGER GmbH,
Hoechberg, Germany, 2012). Experimental runs were performed in physical effort laboratory in standard
conditions (temperature 21 ◦C; atmospheric pressure 1010 hPa; air humidity 55%). Physical tolerance
test was preceded by 5 min warm-up in the form of an ergometric work (Eos Sprint, Jeager, Hoechberg,
Germany) with the load of 1 W/kg, at the rate of 60 rotations per minute. Subsequently, starting with
the sixth minute of test, the load was increased every minute by 0.25 W/kg. The physical activity
was interrupted when the rotation rate decreased by more than 10%, that is less than 54/min. The
highest relative oxygen consumption, maintained for 15 s, at the end of the exercise was considered as
VO2max. The anaerobic Threshold (AT) was determined by the analysis of expiratory gases exhaled
during exercise tolerance test. AT was calculated as a quotient of carbon dioxide exhalation and oxygen
consumption (respiratory exchange ratio—RER). When the calculated value was ≥1, it was assumed
that the AT was reached. After experimental run patients rested sitting for 5 min and the expiratory
gas analyzer was detached.
2.4. The Control of Blood Glucose Concentrations
Raw data from CGM were downloaded and trimmed to include only measurements from the
exercise days. Only records with >70% of expected measurements (200 out of 288) were accepted for
analysis. Gllycemic control parameters (daily mean glucose, standard deviation SD, coefficient of
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variance CV, times above (TAR), in (TIR) and below (TBR) 3.88–10 mmol/L range) were calculated with
Glyculator 2.0. [21]. The insulin dose was assessed as daily insulin dose per kg of body weight (IU/kg).
2.5. Biochemical Analyses
Laboratory tests were performed in accredited Central Laboratory of University Clinical Centre
in Gdan´sk. The biological material for the study was venous blood collected from fasting patients
just before the tests. HbA1c was determined by high-performance liquid chromatography (HPLC)
using the Bio-Rad VARIANT™ HbA1c Program (Bio-Rad Laboratories, Inc., Hercules, CA, USA),
with its values represented as percentages. Serum concentrations of 25(OH)D (reference range 50–75
nmol/L) were measured by chemiluminescence on Liason XL (DiaSorin, Stillwater, Oklahoma USA).
The level of glycated haemoglobin (HbA1c, (<6.5%) was determined by high performance liquid
chromatography (HPLC) using the Variantfrom BioRad. Total cholesterol (2.97–4.91 mmol/L), HDL
cholesterol (>1.03 mmol/L) and triglycerides (<1.69 mmol/L) were measured on analyzers Alinity
(Abbott, Wiesbaden, Germany) using the enzyme-linked immunoassay method, while LDL cholesterol
(<115 mmol/L) was calculated using the Friedewald formula. The levels of thyrotropic hormone
(TSH, 0.35–4.94 uU/mL) and free thyroxine (fT4, 9.01–19.05 pmol/L) were determined by a two-stage
immunochemical method using microparticles and a chemiluminescent marker from Abbott, Germany.
Alanine (<55 U/L), aspargine aminotransferase (5–34 U/L) and urine albumin (<20 mg/L) were
determined by spectrophotometry using an Abbott Alinity analyser (Wiesbaden, Germany).
2.6. Statistical Analyses
The Shapiro–Wilk test was used to assess normal distribution of obtained data. In the case of
normality, t-test for independent samples was applied for group comparison. The nonparametric
U Mann–Whitney test was employed for variables with non-normal distribution. The statistical
significance level was set at p < 0.05. Effect size (ES) for statistical differences was determined using
Cohen’s D [22]. According to Hopkins et al. [23], the ES was classified as trivial (<0.2), small (>0.2–0.6),
moderate (>0.6–1.2), large (>1.2–2.0) and very large (>2.0–4.0). All of the calculations were carried out
using Statistica 13.0 software (Tulsa, OK, USA).
3. Results
Organism response to aerobic and aerobic-anaerobic (mixed) physical activity in the studied
groups is presented in Figure 1. There were no statistically significant differences in VO2 between
DG and SG groups during both exercise tolerance tests as well as within any phase of the tests.
However, in the SG group, the VO2during the aerobic test was lower than in the DG group by ~4%.
Although, the difference between the two groups was higher in case of mixed physical activity by
~5.6%. For every phase of the training, the magnitude effect was calculated in accordance with Hopkins
et al. classification [23]. Its value was at the low level for every phase of aerobic physical activity, and in
case of mixed physical activity, it was low and trivial. There were no differences in any biochemical
blood parameter analysed in both groups of patients. HbA1c level was higher by 6.1% and a total
daily dose of insulin (DDI) was higher by 18.4% in the DG group in comparison with the SG group.
The differences were not statistically significant. In the DG group, TSH concentration was higher
by 18.6% than in the SG group. TSH and FT4 levels, as well as albumin concentration in 24 h urine
collection, were in the normal range and no statistically significant differences have been showed
(Table 2).
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Table 2. Clinical and biochemical comparison of deficient (DG) and suboptimal (SG) 25(OH)D
serum levels.
25(OH)D Status DG(n = 10)
SG
(n = 10) p-Value
HbA1c (%) 7.6 ± 0.8 7.1 ± 0.8 0.2300
DDI (UI/kg) 1.0 ± 0.3 0.8 ± 0.3 0.1926
TSH (µU/mL) 1.6 ± 1.0 1.8 ± 0.5 0.7407
FT4 (pmol/L) 11.9 ± 1.2 11.9 ± 1.1 0.8200
ALAT (U/L) 21.3± 9.6 17.2 ± 4.4 0.3509
ASAT (U/L) 15.6± 4.0 14.3 ± 4.5 0.8003
Total cholesterol (mmol/L) 4.0 ± 0.7 4.2 ± 0.6 0.6903
HDL-cholesterol (mmol/L) 1.5 ± 0.4 1.6 ± 0.5 0.6685
LDL-cholesterol (mmol/L) 2.2 ± 0.5 2.2 ± 0.6 0.9494
Triglycerides (mmol/L) 0.8 ± 0.5 0.7 ± 0.3 0.7056
Urine albumin (mg/L) 6.3 ± 2.2 10.4 ± 4.8 0.1100
DDI—daily dose of insulin [24].
During days with anaerobic training patients with 25(OH)D deficiency demonstrated
insignificantly higher glycaemic variability measured with SD (p = 0.0603) and CV (p = 0.0746).
This finding was reinforced by longer time spent in clinically significant hyperglycaemia >13.9 mmol/L
(p = 0.1862), although these results did not reach statistical significance. Patients from DG group
demonstrated insignificantly higher glycaemic variability measured with SD (p = 0.3218) and CV
(p = 0.1761) during training with aerobic intensity. This finding was reinforced by longer time spent in
clinically significant hyperglycaemia >13.9 mmol/L (p = 0.1864) as well hypoglycemia <3.88 mmol/L
(p = 0.2414), although these results did not reach statistical significance (Table 3).
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Table 3. Comparison of glycaemic control parameters during days of aerobic and mixed exercise
according to 25(OH)D deficiency.
Type of Exercise Mixed Aerobic
25(OH)D Status DG (n = 8) SG (n = 10) p DG (n = 6) SG (n = 9) p
Mean glucose [mmol/L] 7.9 ± 1.6 7.5 ± 1.5 0.5459 7.4 ± 1.5 8.4 ± 1.9 0.3230
SD [mmol/L] 2.5 ± 0.7 1.9 ± 0.5 0.0603 2.9 ± 1.4 2.34 ± 0.4 0.3218
CV [%] 31.3 ± 6.6 26.1 ± 5.0 0.0746 37.5 ± 15.6 29.1 ± 6.8 0.1761
TAR > 13.87 mmol/L [%] 4.2 ± 6.2 0.9 ± 1.6 0.1862 8.9 ± 8.7 3.8 ± 5.6 0.1864
TAR > 10.0 mmol/L [%] 23.5 ± 17.3 15.4 ± 21.8 0.4055 17.3 ± 15.9 25.1 ± 19.6 0.4351
TIR 3.88–10.0 mmol/L [%] 72.3 ± 15.0 81.3 ± 20.9 0.3203 74.1 ± 16.2 70.8 ± 16.7 0.7095
TBR < 3.88 mmol/L [%] 3.9 ± 5.5 2.9 ± 4.0 0.6844 8.2 ± 7.6 3.8 ± 6.3 0.2414
Effects shown as mean ± standard deviations, SD—standard deviation of glycemia, CV—coefficient of variation,
TAR—Time above Range, TIR—Time in Range, TBR—Time Below Range.
During experimental tolerance test with mixed intensity mean glucose concentrations in blood
were higher in the DG group than in the SG group (7.9 ± 1.6 mmol/L versus 7.4 ± 1.5 mmol/L)
(p = 0,5459). Glycaemic variability was also higher in the DG group, CV (31.3 ± 6.6% versus 26.1
± 5.0%) (p = 0.074) and the period with persisting hyperglycaemia above 10.0 mmol/L (time above
range—TAR), was longer (23.5 ± 17.3% versus 15.4 ± 21.8%) (p = 0.4055). In addition, the same group of
patients was more prone to hypoglycemia during mixed training days (time below range < 3.88 mmol/L
(TBR) 8.2 ± 7.6% versus 3.9 ± 5.5%) (p = 0.2414) in comparison with the days with the aerobic training.
4. Discussion
Twenty young boys affected with T1DM participated in the experiment. Due to different vitamin
D levels, patients were divided into two subgroups, the DG group with vitamin D deficiency and the
SG group with suboptimal vitamin D level. Both subgroups were homogeneous regarding biological
development, biometrics and physical capacity (VO2max, VO2/AT) (Figure 1).
The experiment aimed to determine if vitamin D concentration has a significant impact on glycemic
variability in relation to the type of training, with aerobic or anaerobic-aerobic intensity, undertaken
by patients. Researchers decided to examine the issue, due to the lack of publications regarding the
correlation between vitamin D level in children or adolescents with T1DM and effort tolerance.
In the view of results obtained in the experiment, vitamin D deficiency in patients affected with
T1DM may have an unfavorable effect on organism response to the effort tolerance, in case of high
as well as low-intensity physical activities. Furthermore, vitamin D deficiency may be one of the
most significant factors responsible for glycaemic variability (CV%) towards both hyperglycaemia
and hypoglycaemia. Additionally, it may prolong the time spent in hyperglycaemia (TAR) and
hypoglycaemia (TBR) during aerobic and mixed training as well as 24 h after its completion.
The value of VO2max achieved in the study group does not seem to differ considerably from the
group of healthy, not practicing individuals at the same age (Figure 1). The data regarding physical
capacity in adolescents with T1DM are limited and the findings are equivocal. Cuenca-Garcia et al. [25]
have shown the decreased oxygen capacity measured by VO2max in patients affected with T1DMin
comparison to a healthy population. On the other hand, Adolfsson et al. [26] did not demonstrated
substantial differences between such groups in the context of oxygen capacity in response to physical
activity of different intensity. In the presented study researchers have not stated any relevant differences
in VO2maxand VO2/AT between groups with lower and significantly higher vitamin D concentrations.
According to the suggestions of Koundourakis et al. [27] and Jastrze˛bska et al. [28] vitamin D level may
constitute one of the factors influencing substantially the oxygen capacity in young sports athletes.
The volume of oxygen uptake in the DG and the SG group was presented in Figure 1. In spite of the fact
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that significant differences have not been found, patients with higher vitamin D levels consumed less
oxygen during aerobic training by 4.0% and aerobic-anaerobic training by 5.6%. The fundamental goal
of therapy in diabetes is the prevention of acute and chronic complications development. At present,
theHbA1c level is used widely in order to evaluate this risk. In addition, an increasing number of data
indicates that glycaemic variability is responsible for blood vessels damage in diabetic patients. It can
be assessed thanks to better access to CGM. Lending support to this view is the fact that patients with
well-controlled diabetes and low HbA1c levels nevertheless develop chronic and acute complications.
Maiorino et al. [29] and Škrha et al. [30] have assumed that there are pathophysiological premises
suggesting that glycaemic variability may cause damage to the wall of blood vessels, especially to
the endothelium.
The excessive glucose concentration, that is accumulated abruptly in epithelial cells, cannot be
metabolized by glycolysis within an adequately short period of time. It triggers the stimulation of
additional metabolic pathways of glucose and increases the production of reactive oxygen species,
which are toxic to the epithelium. If the energy influx continues to fluctuate rapidly and ensues
the energy deficiency right after the energy excess (what happens in case of a sudden reduction
in glycaemia), then intracellular metabolic mechanisms may dysregulate completely, leading as a
consequence to early degeneration of the cell and its disintegration. Therefore, the factors affecting
glucose concentration and glycaemic variability are the subject of ongoing studies.
In recent years, few studies focusing on the relationship of vitamin D level in T1DM children
with the metabolic control of the disease, insulin sensitivity and development of acute vascular
complications including hyperglycaemia and hypoglycaemia, have been published. It has been
revealed that adequate vitamin D concentration has a beneficial effect on the reduction of the
number of diabetic ketoacidosis [13,24] and hypoglycaemic [12,14] events requiring hospitalization.
However, there are no studies regarding vitamin D level in paediatric population with diabetes, that
take into account the physical activity and the type of training performed by patients.
The active lifestyle is important in the prevention and the treatment of many chronic diseases.
The independent impact of physical activity on diabetes prevention is unknown, however, Petrie et al.
have described its role as a key element of lifestyle modification [1]. Intensified and controlled physical
activity in children with T1DM may improve glycaemic control, insulin sensitivity and prolong the
period of remission in individuals with newly recognized T1DM. Moreover, it helps to prevent vascular
disorders and ameliorates body composition, the quality of life and health throughout the whole life [2].
On the other hand, due to impairment of glycaemic control capacity, patients with T1DM are exposed
to a higher risk of adverse effects like glycaemic variability towards hyper- and hypo-glycaemia, which
can lead to acute, life-threatening complications during physical effort and chronic angiopathies in
the future. Thus, in this group of patients, it is requisite to determine the risk factors of glycaemic
variability during physical activity, considering the type of training as well.
The results of the present study showed that 20 T1DM patients had decreased vitamin D level
(52.3 ± 24.4 nmol/L), which could have a negative impact on their metabolic control. After dividing
the participants into two groups, the DG and the SG group, it was stated that the group of patients
with vitamin D level <50 nmol/L was characterized by worse metabolic control in comparison with
the group with suboptimal vitamin D concentration (HbA1c 7.6 ± 0.8% vs. 7.1 ± 0.8%) and required
higher total daily dose of insulin, though the differences were statistically insignificant (Table 2).
Other researchers confirm this assumption and underline in their works the possibility of insulin
resistance development in case of severe vitamin D deficiency [11,12,24]. Hitherto, only a sparse
number of studies point out the higher risk of diabetic ketoacidosis [13] and the tendency to develop
hypoglycaemia [14,24] in the group of T1DM patients with vitamin D deficiency. However, studies
regarding the reaction of the organism to glucose concentrations and to glycaemic variability in
this group of patients, which take into account the level of vitamin D and the type of performed
training (high or low intensity), were not found in the available literature. In the presented study,
the researchers have proven that T1DM patients with higher vitamin D levels (SG group) had lower
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glycemic variability (SD, CV, Table 3) during the mixed and aerobic training than the participants from
the DG group.
Hence, the authors assume that the results presented in the experiment are innovative and
have essential clinical and therapeutic implications. It is significant that the study was tailored and
conducted in such a manner to exclude the other factors affecting glucose level during physical activity.
The experiment was carried out during the same season, winter (in Northern Europe it is the time of
the most severe vitamin D deficiency among its inhabitants), in the afternoon. The group consisted of
participants of the same sex who performed the physical activity at the same level until the participation
in the study. The tests were conducted after the consumption of the same meal, which constituted the
first breakfast. The periods between the analogue of rapid-acting insulin administration, breakfast and
the beginning of physical activity were equal. Glucose concentration before approaching the training
was in the range of 8.32–10.0 mmol/L. In the study group, all of the other disorders that can affect
glycaemia were excluded (Figure 1).
Preliminary results suggest that vitamin D deficiency in patients with T1DM who perform
exercises at the intensity of aerobic energy transformations, cause high glycaemic variability towards
both hyperglycaemia and life-threatening hypoglycaemia. It is noteworthy that in the group of patients
who accomplished the training at the aerobic-anaerobic intensity, glucose concentrations were higher
with the tendency towards hyperglycaemia. The authors of the study are aware of the fact that the
group size was small. Although the results of the present study are interesting and essential in the
light of clinical experience, they require the confirmation on larger group of patients with T1DM.
5. Conclusions
In conclusion, we assume that adequate vitamin D concentration in blood obtained by vitamin
D supplementation in T1DM patients may constitute a preventive factor for hyperglycaemia during
anaerobic training and hypoglycaemia during aerobic training. Moreover, it may avert the development
of late-onset vascular complications by reduction of glycaemic variability in both types of physical effort.
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